Retrospective evaluation of malignant melanoma patients: A single-center experience by Mustafa Solak, Saadettin Kılıçkap, İsmail Celık

Get full text

Acute Myeloid Leukemia in a Patient with Ovarian Carcinoma by Serdal Korkmaz, Saadettin Kiliçkap, Safak Sahin, Mehmet Sencan

Get full text

Acute Myeloid Leukemia in a Patient with Ovarian Carcinoma by Serdal Korkmaz, Saadettin Kilickap, Safak Sahin, Mehmet sencan

Get full text

AFTER THE SIXTH YEAR SCALP METASTASIS ISOLATED CASE OF BREAST CANCER DIAGNOSIS by Eda Erdiş, Saadettin Kılıçkap, Ebru Atasever Akkaş, Birsen Yücel

Get full text

Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome? by Yeşim S. Karadağ, Aydın Gülünay, Neşe Öztekin, Fikri Ak, Saadettin Kılıçkap

Get full text

Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey by Aysel Çakır, Gonca Elcin, Saadettin Kilickap, Özay Gököz, Zihni Ekim Taskiran, İsmail Celik

Get full text

A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever by Mehmet Bakir , Aynur Engin , Mustafa Gokhan Gozel , Nazif Elaldi , Saadettin Kilickap & Ziynet Cinar

Get full text

Antitumor activity of sorafenib on colorectal cancer by Turgut Kacan, Erdinc Nayir, Ahmet Altun, Saadettin Kilickap, Nalan Akgul Babacan, Hilmi Ataseven, Tijen Kaya

Get full text

Clinical Features and Prognostic Factors of Hodgkin’s Lymphoma: A Single Center Experience by Saadettin Kılıçkap, İbrahim Barışta, Şükran Ülger, İsmail Çelik, Ayşe Kars, Yavuz Özışık, Gülten Tekuzman, Uğur Selek, Ferah Yıldız

Get full text

Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab by Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, Ece Karaca, Yunus Kaygusuz, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap

Get full text

600 Objective response impact on patient reported outcomes (PROs) in patients with aNSCLC with PD-L1 ≥50% receiving cemiplimab versus chemotherapy: EMPOWER-Lung 1 by Mustafa Ozguroglu, Saadettin Kilickap, Igor Bondarenko, Ahmet Sezer, Mahmut Gümüş, Miranda Gogishvili, Xuanyao He, Giuseppe Gullo, Petra Rietschel, Ruben GW Quek

National survey study on the approaches of pediatricians, family physicians, medical oncologists and gynecologists to the HPV vaccine by Ahmet Unlu, M. Dogukan Kalenderoglu, Hale Ay, Ceren Kabaoglu, Z. Lutfullah Koc, D. Ozel Erkan, Seyda Gunduz, Onder Kirca, Saadettin Kılıckap, Mustafa Ozdogan

Get full text

The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis by Mehmet Fuat Eren, Ayfer Ay Eren, Mutlay Sayan, Birsen Yücel, Şahende Elagöz, Yıldıray Özgüven, Irina Vergalasova, Ahmet Altun, Saadettin Kılıçkap, Vasudev Malik Daliparty, Nuran Beşe

Get full text

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study by Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap

Get full text

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors by Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün

Get full text

Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treate... by Nuri Karadurmus, Mehmet Ali Nahit Sendur, Burcak Karaca, Omer Fatih Olmez, Ilhan Hacibekiroglu, Hasan Senol Coskun, Serkan Degirmencioglu, Yasemin Kemal, Saadettin Kilickap, Ahmet Taner Sumbul, Burc Aydin, Hande Turna, Muhammet Ali Kaplan, Nalan Babacan, Umut Demirci, Alper Ata, Dilek Erdem, Ahmet Ozet, Huseyin Abali

Get full text

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study by Hasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabiyev, Miraç Özen, Merve Keskinkılıç, Sercan Ön, Abdussamet Çelebi, Bengü Dursun, Ömer Acar, Seda Kahraman, Musa Barış Aykan, Ömür Kaman, Akif Doğan, Atike Pınar Erdoğan, Özde Melisa Celayir, Damla Günenç, Deniz Can Güven, İbrahim Vedat Bayoğlu, Tuğba Yavuzşen, İlhan Hacıbekiroğlu, Mevlüde İnanç, Saadettin Kılıçkap, Şuayib Yalçın, Sercan Aksoy

Get full text

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer by Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu

Get full text

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases by Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur

Get full text

Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%–89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With Fi... by Biagio Ricciuti, MD, PhD, Arielle Elkrief, MD, Jessica Lin, MD, Jianjun Zhang, MD, Joao V. Alessi, MD, Giuseppe Lamberti, MD, PhD, Malini Gandhi, MD, Alessandro Di Federico, MD, Federica Pecci, MD, Xinan Wang, PhD, Maisam Makarem, MD, PhD, Cassio Murilo Hidalgo Filho, MD, Teresa Gorria, MD, Arushi Saini, BS, Cindy Pabon, MD, James Lindsay, PhD, Kathleen L. Pfaff, PhD, Emma L. Welsh, BS, Mizuki Nishino, MD, Lynette M. Sholl, MD, Scott Rodig, MD, Saadettin Kilickap, MD, Petra Rietschel, MD, Debra AG. McIntyre, PhD, Jean-Francois Pouliot, MD, Mehmet Altan, MD, Justin F. Gainor, MD, John V. Heymach, MD, Adam J. Schoenfeld, MD, Mark M. Awad, MD, PhD

Get full text